A phase 2 study of venetoclax in combination with low-dose cytarabine in relapsing acute myeloid leukemia

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2019
This article has no abstract
Epistemonikos ID: 97ca6ddb1f0a3bc0c6f3d73d3396b29f0f25aed5
First added on: Feb 23, 2025